Sanders Morris Harris LLC cut its holdings in TELA Bio, Inc. (NASDAQ:TELA – Get Rating) by 17.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 69,168 shares of the company’s stock after selling 14,200 shares during the quarter. Sanders Morris Harris LLC owned […]
TELA Bio (NASDAQ:TELA – Get Rating) and Utah Medical Products (NASDAQ:UTMD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations. Profitability This table compares TELA Bio and Utah […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 53,200 shares, a growth of 33.7% from the April 30th total of 39,800 shares. Based on an average trading volume of 59,400 shares, the short-interest ratio is […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 39,800 shares, a decline of 64.7% from the April 15th total of 112,700 shares. Based on an average daily volume of 53,300 shares, the short-interest ratio is […]
TELA Bio (NASDAQ:TELA – Get Rating) and MiMedx Group (NASDAQ:MDXG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Analyst Ratings This is a summary of recent recommendations […]